Stage IV/Metastatic Breast Cancer, Open to All To Contribute
Archives for October 2021
Discussion List
-
Keytruda+Chemo Improves Survival for PD-L1+, TNBC Mets
Adding Keytruda to Chemotherapy Improves Overall Survival in Metastatic, Strongly PD-L1-Positive Triple-Negative Breast Cancer October 5, 2021 Adding the immunotherapy medicine Keytruda to chemotherapy improved overall survival more than chemotherapy alone in people diagnosed with metastatic triple-negative, strongly…
- Fitztwins is gone... 17 years out
Join Us on Zoom: Upcoming virtual meetups. Read more...